What type of study is this?

This is a Case Report study (also classified as: Observational).

September 10, 2025

Immunohistochemical analysis of Progesterone receptors in all Prostatic lesions, Case series study of 40 cases and review of Literature

BSBaani SodhiUnited States Census Bureau JPJyotsna PunjAll India Institute of Medical Sciences Bhopal

Puntos clave

The study found progesterone receptors to be a good prognostic marker for prostate lesions, indicating therapeutic potential.
Among 40 cases, immunohistochemical analysis showed promising results for progesterone receptors in prostate cancer treatment.
Assessment involved various prostate conditions including BPH, prostatitis, and adenocarcinoma, suggesting the heterogeneity of prostate lesions.
While findings support further exploration, more studies are needed to authenticate the role of progesterone receptors in therapy.

Resumen

Background: In scenario of scant data literature, this study was conducted for progesterone receptor as future hormone therapy in prostate lesions especially prostate cancer. Introduction: Prostate cancer as leading cause of mortality, progesterone receptor to be envisaged as future adjunct hormone therapy to reduce morbidity and mortality of prostate. Carcinoma prostate being heterogenous disease, not much is known about biological behaviour of Progesterone receptors. Material and methods: 40 cases of prostate, BHP, BHP with prostatitis, HGPIN and Adenocarcinoma were included where expressions of Progesterone receptors was carried out immunohistochemically. Conclusion: PR analysed as Good prognostic marker, can be authenticated as future adjunct hormone therapy, More Studies required to authenticate it, Our study has been adjunct to that

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo